On currently running projects and new project ideas
TORCH-trial: Tranexamic Acid to Prevent OpeRation in Chronic Subdural Hematoma.
A double-blind, placebo-controlled, multicenter, randomized clinical trial. It aims to evaluate the efficacy of TXA to prevent surgery for CSDH in patients diagnosed with CSDH for which a conservative treatment is selected as primary treatment strategy.
DECSA-trial: DExamethasone therapy in symptomatic patients with Chronic Subdural hematomA.
A prospective, multicenter, randomized controlled trial which aimed to evaluate the effect of initial dexamethasone therapy versus primary surgery on functional outcome and cost-effectiveness, in symptomatic patients with chronic subdural hematoma.